Understanding this has a lot of implications for treatment. They are being treated by current guidelines but still aren't better. Either the guidelines are wrong or it's the wrong therapy for those patients. That's why we're doing this research, to find answers.
We want to use science to guide our therapy for these patients.
The long-term goal is to develop new ways to evaluate a patient's asthma to allow us to design individualized therapy for that patient based on the type of inflammation in their lungs or the genes they have. We are a long way from being there, but this research is a start.